MPR11h
Amvuttra Gains Approval for Transthyretin Amyloid Cardiomyopathy
The Food and Drug Administration (FDA) has approved Amvuttra ® (vutrisiran) for the treatment of the cardiomyopathy of ...
MPR6h
Solriamfetol Significantly Reduces ADHD Symptoms In Phase 3 Trial
Topline data were announced from a phase 3 trial evaluating solriamfetol in adults with attention deficit hyperactivity disorder (ADHD).
MPR7h
Letybo Now Available for Moderate to Severe Glabellar Lines
Letybo, an acetylcholine release inhibitor and a neuromuscular blocking agent, was approved in March 2024 based on data from three phase 3 trials.
MPR9h
Gender-Affirming Hormone Therapy in Primary Care Tied to Reduced Depressive Symptoms
HealthDay News — Gender-affirming hormone therapy (GAHT) in primary care is associated with lower rates of moderate-to-severe depressive symptoms in US transgender, nonbinary, and gender-diverse (TGD) ...
MPR9h
Rare Red Meat Allergy Linked to More Tick Species
New cases suggests that other types of ticks, like the black-legged tick and the western black-legged tick, may also cause the condition.
MPR9h
Kennedy Orders Takedown of Fake CDC Vaccine Web Page
HealthDay News — A fake web page designed to look like the US Centers for Disease Control and Prevention’s (CDC) vaccine safety site has been taken down on orders from health secretary Robert F.
MPR11h
Emrosi Now Available for the Treatment of Rosacea
Emrosi™ (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea ...
MPR11h
Prostate Cancer Imaging Agent Gozellix Gets FDA Approval
According to Telix Pharmaceuticals, the product has a longer shelf-life (up to 6 hours) and an extended distribution radius compared with other gallium-based products.
MPR11h
Fabhalta Approved as First Treatment for C3 Glomerulopathy
The approval of iptacopan in reducing proteinuria in adult patients with native kidney C3G was based on data from the randomized, double-blind, placebo-controlled, phase 3 APPEAR-C3G trial.
MPR1d
Microplastics Found in Filtered Solutions Used for Medical IV Infusions
HealthDay News — Microplastics appear to be present in filtered solutions used for medical intravenous infusions, with about 7500 particles/L found in infusion solutions from polypropylene (PP) ...
MPR1d
FDA Unveils Transparency Tool for Easy Check of Contaminant Levels in Foods
HealthDay News — The US Food and Drug Administration has launched the Chemical Contaminants Transparency Tool (CCT Tool), an online searchable database to evaluate potential health risks of ...
MPR1d
ACP Issues Clinical Guideline for Pharmacologic Treatment of Acute Episodic Migraine
HealthDay News — In a clinical guideline issued by the American College of Physicians (ACP) and published online March 18 in the Annals of Internal Medicine, recommendations are presented for the ...